Market Cap 110.45B
Revenue (ttm) 12.00B
Net Income (ttm) 3.95B
EPS (ttm) N/A
PE Ratio 25.55
Forward PE 25.34
Profit Margin 32.94%
Debt to Equity Ratio 0.00
Volume 1,194,017
Avg Vol 1,284,920
Day's Range N/A - N/A
Shares Out 253.81M
Stochastic %K 86%
Beta 0.30
Analysts Strong Sell
Price Target $550.39

Company Profile

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for peo...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 341 6100
Address:
50 Northern Avenue, Boston, United States
pnvoss
pnvoss May. 13 at 4:40 AM
$SPY made like $600 in $VRTX . My bsx adobe crm starting to bleed. Down 9.5k in those. Holding
1 · Reply
FireLife45
FireLife45 May. 13 at 1:23 AM
$VRTX this week it will hurt shorts! Cover your position
0 · Reply
JFDI
JFDI May. 12 at 6:28 PM
$VRTX 50d squeeze
0 · Reply
NightBreeze
NightBreeze May. 12 at 6:27 PM
$VRTX rippin' 'its. News or just the well deserved and delayed move?
0 · Reply
svertical1
svertical1 May. 12 at 4:48 PM
$VRTX Great info on Share Repurchase Program: Per Grok-
1 · Reply
akinyo
akinyo May. 12 at 4:29 PM
$VRTX good day!
0 · Reply
svertical1
svertical1 May. 12 at 3:29 PM
$VRTX I like the chart. March back to $510 seems reasonable. Catalysts and conferences lining up! Don’t forget about the 60-Day Voucher….120 Days ago.
0 · Reply
FireLife45
FireLife45 May. 12 at 2:44 PM
$VRTX you still have time to cover, don’t wait.
0 · Reply
akinyo
akinyo May. 12 at 2:24 PM
$VRTX El squeezy back to Five Hundrizzy$ 😜
0 · Reply
akinyo
akinyo May. 12 at 2:08 PM
$VRTX my non AI friends are flying today ✌🏻
0 · Reply
Latest News on VRTX
Vertex to Participate in Upcoming May Investor Conferences

May 11, 2026, 4:00 PM EDT - 2 days ago

Vertex to Participate in Upcoming May Investor Conferences


Vertex Pharmaceuticals Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 9 days ago

Vertex Pharmaceuticals Earnings Call Transcript: Q1 2026


Vertex Pharmaceuticals reports Q1 EPS $4.02, consensus $4.31

2026-05-04T20:08:07.000Z - 9 days ago

Vertex Pharmaceuticals reports Q1 EPS $4.02, consensus $4.31


Vertex Reports First Quarter 2026 Financial Results

May 4, 2026, 4:01 PM EDT - 9 days ago

Vertex Reports First Quarter 2026 Financial Results


Vertex passes key test In quest to treat kidney diseases

Mar 10, 2026, 10:54 AM EDT - 2 months ago

Vertex passes key test In quest to treat kidney diseases


Vertex to Participate in Upcoming March Investor Conferences

Mar 5, 2026, 4:00 PM EST - 2 months ago

Vertex to Participate in Upcoming March Investor Conferences


Vertex Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 3 months ago

Vertex Pharmaceuticals Earnings Call Transcript: Q4 2025


Vertex Pharmaceuticals Transcript: Study Update

Nov 8, 2025, 8:00 PM EST - 6 months ago

Vertex Pharmaceuticals Transcript: Study Update


Committee stocks on the move: Uber and Vertex Pharma

Nov 4, 2025, 1:22 PM EST - 6 months ago

Committee stocks on the move: Uber and Vertex Pharma

UBER


Vertex Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 4:30 PM EST - 6 months ago

Vertex Pharmaceuticals Earnings Call Transcript: Q3 2025


Vertex Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 4:02 PM EST - 6 months ago

Vertex Reports Third Quarter 2025 Financial Results


Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR

Oct 2, 2025, 1:31 PM EDT - 7 months ago

Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR

IJR NOW


Vertex Announces Key Advancements Across Kidney Portfolio

Sep 25, 2025, 7:45 AM EDT - 8 months ago

Vertex Announces Key Advancements Across Kidney Portfolio


Calls of the Day: Abbvie, Vertex, Veeva and Vistra

Sep 8, 2025, 1:47 PM EDT - 8 months ago

Calls of the Day: Abbvie, Vertex, Veeva and Vistra

ABBV VEEV VST


Vertex to Participate in Upcoming September Investor Conferences

Aug 20, 2025, 4:00 PM EDT - 9 months ago

Vertex to Participate in Upcoming September Investor Conferences


Vertex Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 4:01 PM EDT - 10 months ago

Vertex Reports Second Quarter 2025 Financial Results


Vertex Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 5:30 AM EDT - 10 months ago

Vertex Pharmaceuticals Earnings Call Transcript: Q2 2025


How Will VRTX Stock React To Its Upcoming Earnings?

Aug 2, 2025, 12:20 AM EDT - 10 months ago

How Will VRTX Stock React To Its Upcoming Earnings?


pnvoss
pnvoss May. 13 at 4:40 AM
$SPY made like $600 in $VRTX . My bsx adobe crm starting to bleed. Down 9.5k in those. Holding
1 · Reply
FireLife45
FireLife45 May. 13 at 1:23 AM
$VRTX this week it will hurt shorts! Cover your position
0 · Reply
JFDI
JFDI May. 12 at 6:28 PM
$VRTX 50d squeeze
0 · Reply
NightBreeze
NightBreeze May. 12 at 6:27 PM
$VRTX rippin' 'its. News or just the well deserved and delayed move?
0 · Reply
svertical1
svertical1 May. 12 at 4:48 PM
$VRTX Great info on Share Repurchase Program: Per Grok-
1 · Reply
akinyo
akinyo May. 12 at 4:29 PM
$VRTX good day!
0 · Reply
svertical1
svertical1 May. 12 at 3:29 PM
$VRTX I like the chart. March back to $510 seems reasonable. Catalysts and conferences lining up! Don’t forget about the 60-Day Voucher….120 Days ago.
0 · Reply
FireLife45
FireLife45 May. 12 at 2:44 PM
$VRTX you still have time to cover, don’t wait.
0 · Reply
akinyo
akinyo May. 12 at 2:24 PM
$VRTX El squeezy back to Five Hundrizzy$ 😜
0 · Reply
akinyo
akinyo May. 12 at 2:08 PM
$VRTX my non AI friends are flying today ✌🏻
0 · Reply
FireLife45
FireLife45 May. 11 at 11:21 PM
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 3:16 PM
$VRTX Current Stock Price: $441.52 Contracts to trade: $442.5 VRTX May 15 2026 Call Entry: $2.05 Exit: $3.83 ROI: 87% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
dens214
dens214 May. 11 at 12:25 PM
$VRTX stock price has steadily declined since the introduction of caskevy. Is there a causal relationship?
1 · Reply
PickAlpha
PickAlpha May. 11 at 11:59 AM
3/6: MoonLake (MLTX) reports positive final pre‑BLA FDA meeting for sonelokimab (SLK) in hidradenitis suppurativa; plans BLA submission end‑Sep 2026 and seeks Priority Review. $MLTX $XBI $IBB $REGN $VRTX
0 · Reply
BioTechHealthX
BioTechHealthX May. 10 at 4:55 PM
$VRTX Vertex Pharmaceuticals is already a powerhouse in cystic fibrosis, but its bigger 2026 story is diversification. With CASGEVY, JOURNAVX, nephrology ambitions, strong revenue growth, and a $13 billion cash position, VRTX may be one of the most serious biotech stocks investors are watching now. https://biotechhealthx.com/biotech-news/is-it-worthy-to-invest-in-vertex-pharmaceuticals-vrtx/
0 · Reply
svertical1
svertical1 May. 10 at 4:00 PM
$VRTX No excuse for Vertex to not fix pricing. Journavx should be priced competitively with other similar pain meds. Then surgeons, anesthesiologists, docs, hospitals, clinics have a reason to prescribe. I practically begged to try Journavx after my shoulder surgery, but consensus from surgeon to nurses, they see the Journavx reps but it’s not priced competitively. So much for worrying about opioid side effects (I have them), or abuse. Bottom line, revenue should be in Billions. Does Journavx work, yeah it appears, but not any better for pain than what surgeons are currently using.
0 · Reply
BioTechHealthX
BioTechHealthX May. 10 at 4:31 AM
$ARGX $MRNA $UTHR $VRTX $DHR Biotech stocks can move fast when clinical trials, FDA approvals, product sales, and investor momentum line up. These top 5 best biotech stocks to watch now could attract attention as healthcare innovation heats up in 2026. https://biotechhealthx.com/biotech-news/top-5-best-biotech-stocks-to-watch-now/
1 · Reply
pnvoss
pnvoss May. 8 at 9:40 PM
$SPY sticking to the plan $BSX $CRM $ADBE $VRTX
0 · Reply
Kool_Aid_Mann
Kool_Aid_Mann May. 8 at 7:53 PM
$VRTX $ALNY $REGN Join MNKD as they approach their May 29th pediatric PDUFA!! This is the one that they have been waiting for for 12 years. Lots of delays, but finally here and likely to be the milestone trigger for a big cash deal with big pharma! On top of that, they just got back the green light for Treprostinil DPI in IPF which had them previously trading over $6 until a spat with their partner UTHR. Now, not only is everything copacetic again, but they have also just announced a new molecule colloboration with bigger potential than Trep, Ralinpag DPI! Big royalty model like $LGND But wait, there's more, there is another PDUFA ahead for them for furoscix on July 26th, that will approve a new auto injector that will make this product best in class and reduce COGs by 70% to create massive profits. And lets not forget that nintedabib DPI just finished 1b and is prime for an upfront cash deal! $VCYT Fireworks ahead, fight the Citadel!
0 · Reply
FireLife45
FireLife45 May. 8 at 6:58 PM
$VRTX powe hour!
0 · Reply
FireLife45
FireLife45 May. 8 at 1:44 PM
$VRTX cover your position today, I am a buyer!
0 · Reply
pilobious
pilobious May. 7 at 7:59 PM
$VRTX $425 is pathetic with all the recent rallies. Might have to move on.
0 · Reply